Security key
682310875
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)
CUSIP: 682310875
Q3 2018 13F Holders as of 30 Sep 2018
- Type / Class
- Equity / Common Stock, no par value
- Shares outstanding
- 109,272,143
- Total 13F shares
- 184,782
- Share change
- -400,796
- Total reported value
- $699,979
- Price per share
- $3.83
- Number of holders
- 16
- Value change
- -$1,552,787
- Number of buys
- 9
- Number of sells
- 8
Report period
Q3 2018
Institutions
16
Top holders
10
ONCY full security history
Newer quarter: Q4 2018
Previous quarter: Q2 2018
ONCOLYTICS BIOTECH INC SEC filings
ONCOLYTICS BIOTECH INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 682310875
Recent filing periods:
Top shareholders of ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.45%
|
489,531
|
$2,692,000 | — | 30 Jun 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
46,958
|
$258,000 | — | 30 Jun 2018 | |
| COMERICA BANK |
13F
|
Company |
0.01%
|
15,526
|
$83,000 | — | 30 Jun 2018 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
8,899
|
$49,000 | — | 30 Jun 2018 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.01%
|
7,985
|
$42,829 | — | 30 Jun 2018 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
5,071
|
$28,000 | — | 30 Jun 2018 | |
| UBS Group AG |
13F
|
Company |
0%
|
4,291
|
$24,000 | — | 30 Jun 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
2,700
|
$15,000 | — | 30 Jun 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,677
|
$9,000 | — | 30 Jun 2018 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
947
|
$5,000 | — | 30 Jun 2018 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0%
|
774
|
$4,000 | — | 30 Jun 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
642
|
$4,000 | — | 30 Jun 2018 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
409
|
$2,000 | — | 30 Jun 2018 | |
| JNBA Financial Advisors |
13F
|
Company |
0%
|
210
|
$1,000 | — | 30 Jun 2018 | |
| TORONTO DOMINION BANK |
13F
|
Company |
0%
|
210
|
$1,000 | — | 30 Jun 2018 | |
| Cable Hill Partners, LLC |
13F
|
Company |
0%
|
157
|
$1,000 | — | 30 Jun 2018 | |
| HOWE & RUSLING INC |
13F
|
Company |
0%
|
105
|
$1,000 | — | 30 Jun 2018 | |
| American Portfolios Advisors |
13F
|
Company |
0%
|
105
|
$563 | — | 30 Jun 2018 |
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q3 2018
As of 30 Sep 2018,
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
184,782 shares.
The largest 10 holders included
MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, COMERICA BANK, ROYAL BANK OF CANADA, Federation des caisses Desjardins du Quebec, UBS Group AG, BANK OF MONTREAL /CAN/, and Intellectus Partners, LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2018 vs Q2 2018 Across Filers
Q2 2018 holders
18
Q3 2018 holders
16
Holder diff
-2
| Investor | Q2 2018 Shares | Q3 2018 Shares | Share Diff | Share Chg % | Q2 2018 Value $ | Q3 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.